Apixaban in Patients With Post-Myocardial Infarction Left Ventricular Thrombus: A Randomized Clinical Trial
Background: Direct oral anticoagulants are frequently used to treat post-myocardial infarction (MI) left ventricular thrombus (LVT). This study was conducted to evaluate the efficacy and safety of use of apixaban, compared to the standard warfarin therapy, in post-MI LVT. Methods: This open-label, r...
Main Authors: | Ali A. Youssef, MD, Mustafa A. Alrefae, MD, Hesham H. Khalil, MD, Hisham I. Abdullah, MD, Zizi S. Khalifa, MD, Amani A. Al Shaban, MSc Pharm, Hammam A. Wali, D Pharm, Mazen R. AlRajab, MD, Omar M. Saleh, MD, Baher N. Nashy, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-03-01
|
Series: | CJC Open |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589790X2200289X |
Similar Items
-
Long-term Anticoagulation with Apixaban in Patients with Cerebral Venous Thrombosis
by: Suman Preet Bharath MD, et al.
Published: (2023-01-01) -
Pulmonary Artery Intimal Sarcoma Mimicking Right Ventricular Outflow Tract Thrombus
by: Hammam Shereef, MD, et al.
Published: (2023-12-01) -
Angioedema Involving the Larynx after Starting Apixaban
by: Adrian Williamson, et al.
Published: (2019-01-01) -
Takotsubo Cardiomyopathy With a Rapidly Resolved Left Ventricular Thrombus
by: Abdel Anabtawi MD, et al.
Published: (2017-09-01) -
Characteristics, Thrombus Resolution, and Long-Term Outcomes in Patients with Nonvalvular Atrial Fibrillation and Atrial Thrombus
by: Shu Yang MM, et al.
Published: (2023-04-01)